Companies / Cytosorbents Corp

Cytosorbents Corp

Nasdaq: CTSOCIK 1175151PRINCETON, NJ

Financials · FY2018

Revenue$22.50M
Net income$-8.20M
Total debt$17.24M
Cash$4.41M
Diluted EPS$-0.13
Shares outstanding62.8M

Ownership

62.8M shares outstanding · as of Jul 31, 2026
3.8%Insiders
Ownership
Insiders3.79%2,382,545
10%+ / strategic8.32%5,230,099
Institutions18.28%11,489,371
Public float69.60%43,740,733

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 2

View all →
Insider% of sharesShares
Chan Phillip P.CEOChief Executive Officer · Director
2.78%1,744,432
Mariani Peter JChief Financial Officer
1.02%638,113

Institutional holders 52

View all →
HolderValue% of shares
Avenir Corp$2.95M8.30%
Vanguard Group Inc$1.41M3.51%
Neuberger Berman Group LLC$1.04M2.59%
Skylands Capital, LLC$967.0K2.72%
CM Management, LLC$943.8K2.35%
Geode Capital Management, LLC$400.6K1.13%
Sargent Investment Group, LLC$391.2K0.97%
Pathstone Holdings, LLC$319.6K0.80%
BlackRock, Inc.$234.6K1.00%
CIBC Private Wealth Group LLC$110.4K0.27%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 12, 2026Chan Phillip P.
CEO
BuyCommon Stock$100.5K+251K
+16.93%
1,734,099
2.76% of shares
medium
Jun 15, 2026Mariani Peter J
Executive
BuyCommon Stock$44.0K+100K
+18.58%
638,113
1.02% of shares
low
Jun 15, 2026Chan Phillip P.
CEO
BuyCommon Stock$4.4K+10K
+0.60%
1,744,432
2.78% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Avenir CorpPassive13G/A—5,230,099—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CTSOCommon StockEquity23283X206BBG000C3P8V0